Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops

NCT02138461 ·Status: COMPLETED

Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma

NCT01361841 ·Status: UNKNOWN ·Phase: NA

Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

NCT00348023 ·Status: COMPLETED ·Phase: PHASE4

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

NCT00441883 ·Status: COMPLETED ·Phase: PHASE2

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

NCT00348400 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT00300443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy of a Drug Delivery System in Glaucoma

NCT01016691 ·Status: COMPLETED ·Phase: PHASE2

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT01830140 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

NCT00847483 ·Status: COMPLETED ·Phase: PHASE4

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%

NCT00440141 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study

NCT00567788 ·Status: UNKNOWN ·Phase: NA

Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated

NCT01243567 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

NCT02247804 ·Status: COMPLETED ·Phase: PHASE3

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

NCT00329095 ·Status: COMPLETED ·Phase: PHASE4

A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

NCT00638742 ·Status: COMPLETED ·Phase: PHASE1

Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate

NCT06730516 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02636946 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension

NCT00348062 ·Status: COMPLETED ·Phase: PHASE4

An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects

NCT00811564 ·Status: COMPLETED ·Phase: PHASE4

Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study

NCT01975714 ·Status: COMPLETED ·Phase: PHASE4

24-hour IOP-lowering Effect of 0.01% Bimatoprost

NCT01271686 ·Status: COMPLETED ·Phase: PHASE4

Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures

NCT02154217 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

NCT00572455 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

NCT00538304 ·Status: COMPLETED ·Phase: PHASE2